You are here
Thailand is a large country located at the center of the Indochina peninsula in South East Asia. It is the only country in the region never colonized by a foreign power, and has a long and successful history of health development.
- Homogenous Thai population
- Strong history of health development
- High regulatory and ethical standards
- Internationally trained doctors and medical personnel
- Government support for medical research industry.
Thailand offers universal healthcare to its citizens, but despite ongoing improvements, communicable diseases remain a serious public health issue, especially in regional areas. HIV/AIDS has an increasing prevalence (1.5% of all persons aged 15-49 years).
High prevalence diseases include:
- Infectious diseases
- Heart disease.
Clinical Trial Landscape
Hundreds of clinical trials are conducted in Thailand every year; however there still are fewer competing trials than in more developed economies. The Government is dedicated to promoting the conduct of clinical studies to comply with GCP and establish the country as a world-class center of excellence in clinical trials.
Thailand FDA (TFDA) approval is required for Investigational Product and medical devices that need to be imported. The TFDA follows EMA and US FDA guidelines.
The average timeline for regulatory and IRB approval is 4-5 months.
67.7 million people
34.1% reside in urban areas
93.5% literacy rate
- Novotech opened its first Thai contract research organization (CRO) office in 2010
Why choose Thailand for clinical research?
There are many compelling reasons to consider contract research organizations in Thailand for your clinical research:
- Large patient population
- Few competing trials
- Efficient regulatory system
- Highly qualified and educated medical professionals
- Low operational costs
- Well supported IT infrastructure
- High level of GCP compliance
- Efficient trial management and logistics infrastructure.